Pharmacy Times® interviewed John Beckner, the senior director of strategic initiatives at the National Community Pharmacists Association, on some of the challenges community pharmacies may need to manage when receiving and administering COVID-19 vaccines.
Pharmacy Times® interviewed John Beckner, the senior director of strategic initiatives at the National Community Pharmacists Association, on the work needed to prepare for the arrival and administration of COVID-19 vaccines.
Results of Ellume’s rapid at-home COVID-19 test are sent to a smartphone in 15 minutes or less.
There are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
Tips and tricks to make mask-wearing less problematic during the COVID-19 pandemic.
Although cytokine storms are usually associated with severe COVID-19, study indicates less severe disease may also be at risk of cytokine storm.
A thorough understanding of immunization billing processes for Medicare, Medicaid, and other third-party payers will be critical to ensure pharmacy staff can efficiently serve their communities and facilitate a smooth reimbursement process.
Among a subset of participants in the COVID-19 vaccine clinical trials, 0.63% of individuals in the vaccinated group had hypersensitivity-related adverse events that may represent allergic reactions.
Under the 340B Prime Vendor Program, the Prime Vendor has several functions that it carries out to support stakeholders in operating and navigate the field so that they can effectively achieve lower 340B drug pricing for those who need it most.
The FDA is expected to review the safety and efficacy data package from Moderna's COVID-19 vaccine candidate on December 17, which could lead to an EUA being issued this week.
As administration of COVID-19 begins, pharmacies are preparing to vaccinate millions of people, not only once but twice.
Learn how you and your staff can help patients differentiate between common cough/cold symptoms and COVID-19 while also offering additional educational resources.
Pharmacy Times® interviewed Signe Pringle, the assistant secretary for the Maryland Department of Commerce, on a signed partnership between Quebec and Maryland to foster collaboration around health science research during COVID-19 and beyond.
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Delirium is a common syndrome experienced by patients with COVID-19 while being treated in the ICU, according to a session at the 2020 ASHP Midyear Clinical Meeting and Exhibition.
The COVID-19 pandemic has shed light on the need to further expand the accessible, trusted care provided by community pharmacies.
Distribution of the first 2.9 million doses of the COVID--19 vaccine jointly developed by Pfizer and BioNTech are expected to begin within hours of the FDA’s decision.
A member of the FDA’s expert advisory committee who voted in favor of Pfizer and BioNTech’s COVID-19 vaccine said that distribution of the first vaccines to high priority populations in the United States could begin as early as Monday.
The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
As the number of patients hospitalized with COVID-19 has surged, hospitals have been faced with the challenge of converting various spaces into ICUs and COVID-19 units.
The objective of the study was to increase awareness among pharmacists about products for which unfounded claims have been made regarding prevention of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infections.
Direct-to-consumer COVID-19 kit allows for anyone over 18 years of age to perform a nasal swab on themselves and send the sample off for testing.
Until COVID-19 vaccines are widely available, Anthony Fauci, MD, said the importance of public health measures cannot be understated.
Pharmacists can provide a multitude of billing opportunities for their health systems and bringing these opportunities to executives is essential during a time of budget tightening.
The early stage of COVID-19 is typically characterized by lymphocytopenia and thrombocytopenia, whereas the late stage may be characterized by more severe lymphocytopenia and other changes.
